3,000 volunteers to reveal hidden heart risks in qatar

NCT ID NCT07675928

Not yet recruiting Knowledge-focused Sponsor: Weill Cornell Medical College in Qatar Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study follows 3,000 adults in Qatar—both citizens and long-term residents—to track how cardiometabolic conditions like diabetes and heart disease develop over time. Participants are grouped by blood sugar status (normal, pre-diabetes, or diabetes) and monitored for major cardiovascular events such as heart attacks and strokes. The goal is to identify risk factors and improve prevention strategies for these common diseases.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could reveal key risk factors and patterns that help prevent heart attacks and strokes in diverse populations.
What could go wrong: This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to other regions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atherosclerosis atherosclerotic cardiovascular disease diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOMETABOLIC DISEASES

Contacts and locations

Locations

Hamad Medical Corporation

Doha, Qatar

More trials for these conditions

Other studies related to the condition(s) this trial covers.